Combination therapy of p53 gene along with gemcitabine encapsulated in a delivery vehicle therefore would be a promising approach to augment therapeutic benefits and overcome challenges associated with pancreatic cancer treatment. Here, TP53 is linked to familial pancreatic carcinoma.